Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-19

Clinical Trial Update: Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 trial update regarding restarting direct oral anticoagulants after traumatic intracranial hemorrhage, with a protocol restart.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas at Austin | Conditions: Anticoagulants; Increased | Phase 3 | Status: UNKNOWN